Information on the Total Number of Voting Rights (Denominator) following Conversion Notice from NEGMA novembre 4, 20220CommentsEN NL Read More
Oxurion Receives Transparency Notification from Fidelity Management & Research Company LLC novembre 4, 20220CommentsEN NL Read More
Information on the Total Number of Voting Rights (Denominator) following Conversion Notice from NEGMA octobre 28, 20220CommentsEN NL Read More
American Academy of Ophthalmology (AAO) 2022 Annual Meeting – Chicago, IL septembre 30, 20220Comments Read More
Information on the Total Number of Voting Rights (Denominator) following Conversion Notice from NEGMA septembre 30, 20220CommentsEN NL Read More
Oxurion To Participate in Upcoming Scientific and Investor Conferences septembre 12, 20220CommentsEN Read More
Speciaal verslag van de Raad van Bestuur – 2 september 2022 septembre 2, 20220CommentsSpeciaal verslag van de Raad van Bestuur Read More
Beoordelingsverslag van de commissaris aan de Raad van Bestuur – 2 september 2022 septembre 2, 20220CommentsAuditor's Report to the Board of Directors (NL only) Read More
Board of Directors Special Report – September 2, 2022 septembre 2, 20220CommentsSpecial report of the Board of Directors Read More
Beoordelingsverslag van de commissaris aan de Raad van Bestuur – 2 september 2022 septembre 2, 20220CommentsAuditor's Report to the Board of Directors (NL only) Read More
Oxurion Announces Amendment to Funding Program with Negma Group for EUR 6 Million in Funding septembre 2, 20220CommentsEN NL Read More
Prospectus Nieuwe Aandelen – 30 augustus 2022 août 30, 20220CommentsProspectus voor de toelating tot de handel op Euronext Brussels van maximal 30.500.000 nieuwe aandelen Read More
Supplement op het Prospectus d.d. 30 augustus 2022 août 30, 20220CommentsSupplement op het Prospectus d.d. 30 augustus 2022 Read More
New Shares Prospectus – August 30, 2022 août 30, 20220CommentsProspectus for the admission to trading on Euronext Brussels of up to 30,500,000 new shares Read More
Supplement to the Prospectus of 30 August 2022 août 30, 20220CommentsSupplement to the Prospectus of 30 August 2022 Read More
Information on the Total Number of Voting Rights (Denominator) following Conversion Notice from NEGMA août 26, 20220CommentsEN NL Read More
Oxurion To Present at Upcoming Scientific and Investor Conferences août 24, 20220CommentsEN Read More
Information on the Total Number of Voting Rights (Denominator) following Conversion Notice from NEGMA juillet 29, 20220CommentsEN NL Read More
